Effects of PK 8165, a partial benzodiazepine receptor agonist, on cholecystokinin-induced activation of hippocampal pyramidal neurons: a microiontophoretic study in the rat.
暂无分享,去创建一个
[1] C. Montigny,et al. Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones , 1984, Nature.
[2] G. Fur,et al. Biochemical evidence that 2-phenyl-4[2-(4-piperidinyl) ethyl]quinoline, a quinoline derivative with pure anticonflict properties, is a partial agonist of benzodiazepine receptors , 1984, Neuropharmacology.
[3] S. File,et al. Behavioural effects of PK 8165 that are not mediated by benzodiazepine binding sites , 1984, Neuroscience Letters.
[4] J. Simiand,et al. The quinolines PK 8165 and PK 9084 possess benzodiazepine-like activity in vitro but not in vivo , 1984, Neuroscience Letters.
[5] H. Yamamura,et al. PK 8165 and PK 9084, two quinoline derivatives with anxiolytic properties, antagonize the anticonvulsant effects of diazepam , 1983, Brain Research.
[6] B. Beer,et al. Molecular substrates of anxiety: clues from the heterogeneity of benzodiazepine receptors. , 1982, Life sciences.
[7] M. Morelli,et al. The effect of GABA on in vitro binding of two novel non-benzodiazepines, PK 8165 and CGS 8216, to benzodiazepine receptors in the rat brain. , 1982, Life sciences.
[8] L. Pieri,et al. Selective antagonists of benzodiazepines , 1981, Nature.
[9] M. Héaulme,et al. Multiple benzodiazepine receptors: evidence of dissociation between anticonflict and anticonvulsant properties by PK 8165 and PK 9084 (two quinoline derivatives). , 1981, Life sciences.
[10] J. Kelly,et al. The actions of cholecystokinin and related peptides on pyramidal neurones of the mammalian hippocampus , 1981, Brain Research.
[11] E. Pimentel,et al. Accumulation of Excessive Doses of Iodide by the Thyroid Gland of Normal, Hypophysectomized and Thyroxine-treated Rats , 1966, Nature.